Health Discovery Corp (HDVY)

[bio-gold]

Questions, questions, questions...

Based on the following assumptions:

1. Testing for the HDC bio-markers on tissue samples produced a specificity of 93%.

2. Testing the HDC bio-markers in urine spiked with cells produced similar results.

3. Cells are sloughed off into the urine, especially after a DRE, as seen in the PCA3 test results.

What could go wrong to prevent the HDC test from becoming a viable product?

Is it that there are not enough cells in the urine sample?

That a test cannot be developed that is commercially viable?

That Quest and Abbott may have commercial reasons for not wanting to introduce the test?

If anyone can shed some light, please do so.